ProKidney Corp. Class A Ordinary Shares (PROK) is a publicly traded Healthcare sector company. As of August 10, 2026, PROK trades at $1.66 with a market cap of $336.53M and a P/E ratio of 0.00. PROK moved +3.05% today. Year to date, PROK is -24.55%; over the trailing twelve months it is -34.75%. Its 52-week range spans $0.46 to $7.13. Analyst consensus is neutral with an average price target of $5.75. Rallies surfaces PROK's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies community data for PROK shows anonymized retail investor ownership, positioning, sentiment, and portfolio context when enough community data is available.
| Metric | Value |
|---|---|
| Price | $1.66 |
| Market Cap | $336.53M |
| P/E Ratio | 0.00 |
| EPS | $0.00 |
| Dividend Yield | 0.00% |
| 52-Week High | $7.13 |
| 52-Week Low | $0.46 |
| Volume | 1.15M |
| Avg Volume | 0 |
| Revenue (TTM) | $889.00K |
| Net Income | $-156.28M |
| Gross Margin | 0.00% |
4 analysts cover PROK: 0 strong buy, 2 buy, 1 hold, 1 sell, 0 strong sell. Consensus rating is neutral. Average price target: $5.75.